The Pediatric Brain Tumors Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Pediatric Brain Tumors Market?
The Pediatric Brain Tumors Global Market Report 2025 has been experiencing a significant uptrend. The market size, which sat at $1.4 billion in 2024, will rise to $1.5 billion in 2025. This represents a compound annual growth rate (CAGR) of 7.1%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Pediatric Brain Tumors Industry?
The Pediatric Brain Tumors Global Market Report 2025 forecasts that by 2029, the market size will reach $1.83 billion, growing at a compound annual growth rate (CAGR) of 5.1%.
Download Your Free Sample of the 2025 Pediatric Brain Tumors Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Pediatric Brain Tumors Market?
The key drivers in the pediatric brain tumors market are:
• Precision medicine and molecular profiling advancements
• The development and utilization of targeted therapies
• Rising healthcare infrastructure globally
• Extended insurance coverage for pediatric brain tumor treatments
Global Market Segmentation: Identifying Major Pediatric Brain Tumors Industry Segments
The pediatric brain tumors market covered in this report is segmented –
1) By Type: Gliomas, Mixed Neuronal-Glial Tumors, Embryonal Tumors, Choroid Plexus Papilloma Or Carcinoma, Tumors Arising From Non-Neuroepithelial Tissue, Meningeal Tumors
2) By Treatment Type: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy
3) By Diagnosis Method: Imaging Techniques, Biopsy, Neurological Exam, Lumbar Puncture
4) By Age Group: Infants, Toddlers, Children, Adolescents
5) By Application: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other Applications
Subsegments:
1) By Gliomas: Low-Grade Gliomas, High-Grade Gliomas
2) By Mixed Neuronal-Glial Tumors: Gangliogliomas, Dysembryoplastic Neuroepithelial Tumors (DNET)
3) By Embryonal Tumors: Medulloblastoma, Atypical Teratoid Rhabdoid Tumor (ATRT), Primitive Neuroectodermal Tumors (PNET)
4) By Choroid Plexus Papilloma or Carcinoma: Choroid Plexus Papilloma, Choroid Plexus Carcinoma
5) By Tumors Arising from Non-Neuroepithelial Tissue: Rhabdomyosarcoma, Ewing's Sarcoma
6) By Meningeal Tumors: Meningiomas, Hemangiopericytomas
Pre-order the 2025 Pediatric Brain Tumors Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Pediatric Brain Tumors Market?
The key trends in the pediatric brain tumors market are:
• The future of the market is being shaped by advancements in MRI, PET, and CT scanning technologies.
• The use of genetic and molecular profiling in the treatment of pediatric brain tumors is another emerging trend.
• A new development shaping the market is the growing use of targeted therapies in treatment.
• The introduction of immunotherapies and rise of minimally invasive surgical techniques are also significant trends.
Who Are the Top Competitors & Leading Players in the Pediatric Brain Tumors Market?
Major players in the pediatric brain tumors market are:
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Roche Holding AG
• Takeda Pharmaceutical Company
• UCLA Health
• Ipsen Pharma
• Novocure
• Blueprint Medicines
• Karyopharm Therapeutics Inc.
• Renaissance Pharma
• Servier Laboratories
• Matica Biotechnology
• Curis Inc.
• Oncoheroes Biosciences
• Treovir Inc.
• Plus Therapeutics Inc.
• Stemline Therapeutics Inc.
• BrainChild Bio Inc.
• Seattle Children's Therapeutics
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the pediatric brain tumors market in 2024
